Related Experiment Video
Updated: Oct 13, 2026

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
Differential polyadenylation of the mutant vasopressin mRNA during development of Brattleboro rats
1Institut für Zellbiochemie und klinische Neurobiologie, Universitäts-Krankenhaus, Eppendorf, Hamburg, FRG.
Abstract:
In the normal (Wistar) rat vasopressin encoding mRNA first appears at embryonic day 15 as demonstrated by in situ hybridization of hypothalamic sections. In mutant (Brattleboro) rats, which possess a defective vasopressin gene with a single nucleotide deletion, the corresponding transcript is not detectable before fetal day 18. In both rat strains however expression of the structurally related oxytocin gene begins at fetal day 19. Whereas normal and mutant vasopressin encoding mRNAs are identical in size up to at least three weeks after birth, the corresponding transcripts from adult Brattleboro but not from normal rats are markedly larger. This increase in size is due to a longer stretch of poly(A) sequence as demonstrated by treatment of the respective mRNAs with RNase H and oligo(dT). Thus the mutant vasopressin gene transcript is subject to a cellular-specific differential polyadenylation process during development.
Insights
Vasopressin mRNA expression begins earlier in normal rats than in Brattleboro rats. Mutant vasopressin transcripts show developmental changes in polyadenylation, impacting gene expression.
Area of Science:
- Neuroscience
- Molecular Biology
- Developmental Biology
Background:
- Vasopressin is a crucial neurohormone involved in regulating water balance and blood pressure.
- The Brattleboro rat is a genetic model with a defective vasopressin gene, exhibiting diabetes insipidus.
Purpose of the Study:
- To investigate the developmental expression patterns of vasopressin mRNA in normal and Brattleboro rats.
- To analyze differences in vasopressin mRNA size and polyadenylation during development between the two rat strains.
Main Methods:
- In situ hybridization of hypothalamic sections to detect mRNA.
- Analysis of mRNA size and polyadenylation using RNase H and oligo(dT) treatment.
Main Results:
- Vasopressin mRNA appears at embryonic day 15 in Wistar rats and not before fetal day 18 in Brattleboro rats.
- Oxytocin gene expression begins at fetal day 19 in both strains.
- Adult Brattleboro rats exhibit larger vasopressin transcripts due to extended poly(A) sequences, unlike normal rats.
Conclusions:
- The mutant vasopressin gene transcript in Brattleboro rats undergoes cellular-specific differential polyadenylation during development.
- This altered polyadenylation may contribute to the physiological differences observed in Brattleboro rats.
Related Concept Videos
RNA Splicing
RNA Editing

